Search research articles
Contact Us
Filters
Showing results (161-170 of 194) with videos related to
Page
of 20
Sort By:
Frontiers in Neuroscience
|
May 26, 2023
Validation of a pharmacological imaging challenge using <sup>11</sup>C-buprenorphine and <sup>18</sup>F-2-fluoro-2-deoxy-D-glucose positron emission tomography to study the effects of buprenorphine to the rat brain
Amélie Soyer, Sarah Leterrier, Louise Breuil, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
July 2, 2025
Imaging P-glycoprotein function at the blood-brain barrier in drug-resistant epilepsy using [<sup>11</sup>C]metoclopramide
Louise Breuil, Inès Arino, Myriam El Biali, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
November 22, 2022
[<sup>11</sup>C]glyburide PET imaging for quantitative determination of the importance of Organic Anion-Transporting Polypeptide transporter function in the human liver and whole-body
Solène Marie, Louise Breuil, Zacharias Chalampalakis, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
August 10, 2023
Imaging the impact of blood-brain barrier disruption induced by focused ultrasound on P-glycoprotein function
Sébastien Goutal, Anthony Novell, Sarah Leterrier, et al.
Molecular Pharmaceutics
|
January 30, 2019
Inhibition of ABCB1 and ABCG2 at the Mouse Blood-Brain Barrier with Marketed Drugs To Improve Brain Delivery of the Model ABCB1/ABCG2 Substrate [<sup>11</sup>C]erlotinib
Alexander Traxl, Severin Mairinger, Thomas Filip, et al.
Critical Care Medicine
|
September 15, 2012
Respiratory toxicity of buprenorphine results from the blockage of P-glycoprotein-mediated efflux of norbuprenorphine at the blood-brain barrier in mice
Hisham Alhaddad, Salvatore Cisternino, Xavier Declèves, et al.
The AAPS Journal
|
August 3, 2013
Effects of selected OATP and/or ABC transporter inhibitors on the brain and whole-body distribution of glyburide
Nicolas Tournier, Wadad Saba, Salvatore Cisternino, et al.
Frontiers in Immunology
|
March 27, 2023
Long-term systemic and mucosal SARS-CoV-2 IgA response and its association with persistent smell and taste disorders
Jessica Denis, Annabelle Garnier, Laurence Cheutin, et al.
ACS Pharmacology & Translational Science
|
February 20, 2025
Synaptic Vesicle 2A (SV2A) Positron Emission Tomography (PET) Imaging as a Marker of Therapeutic Response in a Mouse Model of Depression
Cassandre Corvo, Indira Mendez-David, Sébastien Goutal, et al.
Molecular Pharmaceutics
|
January 16, 2024
Performance and Sensitivity of [<sup>99m</sup>Tc]Tc-sestamibi Compared with Positron Emission Tomography Radiotracers to Measure P-glycoprotein Function in the Kidneys and Liver
Irene Hernández-Lozano, Sarah Leterrier, Severin Mairinger, et al.
Page
of 20
Search research articles
Search
Showing results (161-170 of 194) with videos related to
Sort By:
Page
of 20
Frontiers in Neuroscience
|
May 26, 2023
Validation of a pharmacological imaging challenge using <sup>11</sup>C-buprenorphine and <sup>18</sup>F-2-fluoro-2-deoxy-D-glucose positron emission tomography to study the effects of buprenorphine to the rat brain
Amélie Soyer, Sarah Leterrier, Louise Breuil, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
July 2, 2025
Imaging P-glycoprotein function at the blood-brain barrier in drug-resistant epilepsy using [<sup>11</sup>C]metoclopramide
Louise Breuil, Inès Arino, Myriam El Biali, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
November 22, 2022
[<sup>11</sup>C]glyburide PET imaging for quantitative determination of the importance of Organic Anion-Transporting Polypeptide transporter function in the human liver and whole-body
Solène Marie, Louise Breuil, Zacharias Chalampalakis, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
August 10, 2023
Imaging the impact of blood-brain barrier disruption induced by focused ultrasound on P-glycoprotein function
Sébastien Goutal, Anthony Novell, Sarah Leterrier, et al.
Molecular Pharmaceutics
|
January 30, 2019
Inhibition of ABCB1 and ABCG2 at the Mouse Blood-Brain Barrier with Marketed Drugs To Improve Brain Delivery of the Model ABCB1/ABCG2 Substrate [<sup>11</sup>C]erlotinib
Alexander Traxl, Severin Mairinger, Thomas Filip, et al.
Critical Care Medicine
|
September 15, 2012
Respiratory toxicity of buprenorphine results from the blockage of P-glycoprotein-mediated efflux of norbuprenorphine at the blood-brain barrier in mice
Hisham Alhaddad, Salvatore Cisternino, Xavier Declèves, et al.
The AAPS Journal
|
August 3, 2013
Effects of selected OATP and/or ABC transporter inhibitors on the brain and whole-body distribution of glyburide
Nicolas Tournier, Wadad Saba, Salvatore Cisternino, et al.
Frontiers in Immunology
|
March 27, 2023
Long-term systemic and mucosal SARS-CoV-2 IgA response and its association with persistent smell and taste disorders
Jessica Denis, Annabelle Garnier, Laurence Cheutin, et al.
ACS Pharmacology & Translational Science
|
February 20, 2025
Synaptic Vesicle 2A (SV2A) Positron Emission Tomography (PET) Imaging as a Marker of Therapeutic Response in a Mouse Model of Depression
Cassandre Corvo, Indira Mendez-David, Sébastien Goutal, et al.
Molecular Pharmaceutics
|
January 16, 2024
Performance and Sensitivity of [<sup>99m</sup>Tc]Tc-sestamibi Compared with Positron Emission Tomography Radiotracers to Measure P-glycoprotein Function in the Kidneys and Liver
Irene Hernández-Lozano, Sarah Leterrier, Severin Mairinger, et al.
Page
of 20